Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.24 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMII) Payables (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMII) posted Payables of $462,253 for Q2 2026, down 7.4% from the prior quarter.

Analysis

Drugs Made In America Acquisition (DMII) Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Drugs Made In America Acquisition's Payables came in at $99,359, down 60.3% from FY2024.

  • In prior years, Drugs Made In America Acquisition's Payables was $250,100 in FY2024.
  • Quarterly Payables has run from a low of $4,592 in Q3 2025 to a high of $499,166 in Q1 2026 over five years.
  • According to Business Quant data, Payables for the three prior quarters was $499,166 (Q1 2026), $99,359 (Q4 2025) and $4,592 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - 1.98 Bn
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - 45.42 Mn
3 Brookfield 101.47 Bn -96.66 Bn - 62.41 Bn
4 Blackstone 91.35 Bn 85.56 Bn - 3.43 Bn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn 22.41 Bn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - 4.33 Bn
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn 4.42 Bn
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn 16.44 Mn
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn 1.42 Bn
10 Drugs Made In America Acquisition 652.29 Mn 651.45 Mn - 462,253.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 462,253.00
Mar 31, 2026 499,166.00
Dec 31, 2025 99,359.00
Sep 30, 2025 4,592.00
Dec 31, 2024 250,100.00
API Access

Drugs Made In America Acquisition Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=DMII&period=max&api_key=YOUR_API_KEY